Statin-associated new-onset diabetes mellitus and insulin resistance: a 30-year bibliometric study (1992- 2022)

Statins are widely used lipid-lowering drugs that are relatively well-tolerated and have an established safety profile. However, statin therapy has been reported to increase the risk of developing new-onset type 2 diabetes mellitus (NOD2). Although this side effect is rare, research on this topic is...

Full description

Bibliographic Details
Published in:Biomedical Research and Therapy
Main Author: Kamisah Y.; Nordin A.H.; Harafinova H.-S.; Nordin M.L.; Nurhidayah M.; Muhammad N.A.; Qodriyah H.M.S.; Abdullah A.; Mohd-Fahami N.A.; Masbah N.; Siti H.N.
Format: Review
Language:English
Published: BiomedPress 2023
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85192647030&doi=10.15419%2fbmrat.v10i11.845&partnerID=40&md5=82bdb2aefc20f9440b975365c0cd4451

Similar Items